201 related articles for article (PubMed ID: 14578459)
1. Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells.
Collisson EA; Kleer C; Wu M; De A; Gambhir SS; Merajver SD; Kolodney MS
Mol Cancer Ther; 2003 Oct; 2(10):941-8. PubMed ID: 14578459
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis.
Islam M; Sharma S; Kumar B; Teknos TN
Oral Oncol; 2013 Aug; 49(8):778-86. PubMed ID: 23648017
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin.
Li M; Liu Y; Dutt P; Fanburg BL; Toksoz D
Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L463-71. PubMed ID: 17545489
[TBL] [Abstract][Full Text] [Related]
4. The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk.
Arpaia E; Blaser H; Quintela-Fandino M; Duncan G; Leong HS; Ablack A; Nambiar SC; Lind EF; Silvester J; Fleming CK; Rufini A; Tusche MW; Brüstle A; Ohashi PS; Lewis JD; Mak TW
Oncogene; 2012 Feb; 31(7):884-96. PubMed ID: 21765460
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion.
Fromigué O; Hamidouche Z; Marie PJ
J Biol Chem; 2008 Nov; 283(45):30549-56. PubMed ID: 18757369
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Rho and Rac geranylgeranylation by atorvastatin is critical for preservation of endothelial junction integrity.
Xiao H; Qin X; Ping D; Zuo K
PLoS One; 2013; 8(3):e59233. PubMed ID: 23555637
[TBL] [Abstract][Full Text] [Related]
7. Isoprenylation is necessary for the full invasive potential of RhoA overexpression in human melanoma cells.
Collisson EA; Carranza DC; Chen IY; Kolodney MS
J Invest Dermatol; 2002 Nov; 119(5):1172-6. PubMed ID: 12445208
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity.
Finlay GA; Malhowski AJ; Liu Y; Fanburg BL; Kwiatkowski DJ; Toksoz D
Cancer Res; 2007 Oct; 67(20):9878-86. PubMed ID: 17942919
[TBL] [Abstract][Full Text] [Related]
9. A definitive role of RhoC in metastasis of orthotopic lung cancer in mice.
Ikoma T; Takahashi T; Nagano S; Li YM; Ohno Y; Ando K; Fujiwara T; Fujiwara H; Kosai K
Clin Cancer Res; 2004 Feb; 10(3):1192-200. PubMed ID: 14871999
[TBL] [Abstract][Full Text] [Related]
10. Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors.
Rashid M; Tawara S; Fukumoto Y; Seto M; Yano K; Shimokawa H
Circ J; 2009 Feb; 73(2):361-70. PubMed ID: 19060417
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis.
Shachaf CM; Perez OD; Youssef S; Fan AC; Elchuri S; Goldstein MJ; Shirer AE; Sharpe O; Chen J; Mitchell DJ; Chang M; Nolan GP; Steinman L; Felsher DW
Blood; 2007 Oct; 110(7):2674-84. PubMed ID: 17622571
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma.
Haak AJ; Appleton KM; Lisabeth EM; Misek SA; Ji Y; Wade SM; Bell JL; Rockwell CE; Airik M; Krook MA; Larsen SD; Verhaegen M; Lawlor ER; Neubig RR
Mol Cancer Ther; 2017 Jan; 16(1):193-204. PubMed ID: 27837031
[TBL] [Abstract][Full Text] [Related]
14. A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC.
Hoshino D; Koshikawa N; Seiki M
J Biol Chem; 2011 Jan; 286(4):3139-48. PubMed ID: 21087931
[TBL] [Abstract][Full Text] [Related]
15. Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes.
Takaguri A; Satoh K; Itagaki M; Tokumitsu Y; Ichihara K
J Pharmacol Sci; 2008 May; 107(1):80-9. PubMed ID: 18469500
[TBL] [Abstract][Full Text] [Related]
16. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
[TBL] [Abstract][Full Text] [Related]
17. MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase.
Cao Z; Fan-Minogue H; Bellovin DI; Yevtodiyenko A; Arzeno J; Yang Q; Gambhir SS; Felsher DW
Cancer Res; 2011 Mar; 71(6):2286-97. PubMed ID: 21262914
[TBL] [Abstract][Full Text] [Related]
18. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
Wagner AH; Gebauer M; Güldenzoph B; Hecker M
Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
[TBL] [Abstract][Full Text] [Related]
19. Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA/ROCK pathway in murine melanoma cells.
Sarrabayrouse G; Synaeve C; Leveque K; Favre G; Tilkin-Mariamé AF
Neoplasia; 2007 Dec; 9(12):1078-90. PubMed ID: 18084615
[TBL] [Abstract][Full Text] [Related]
20. Impact of HMG CoA reductase inhibition on small GTPases in the heart.
Laufs U; Kilter H; Konkol C; Wassmann S; Böhm M; Nickenig G
Cardiovasc Res; 2002 Mar; 53(4):911-20. PubMed ID: 11922901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
